This article provides an update on the studies on nicotine from cigarette smoking and diet and Parkinson disease, indicating that nicotine from other sources, such as diet, could be a promising therapeutic substance for protection against the disease.

Read the article

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

The publication costs for Translational Neurodegeneration are covered by Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China, so authors do not need to pay an article-processing charge for each article accepted for publication.

Update on Amyotrophic lateral sclerosis: from genetic and mitochondria perspective
Edited by Shengdi Chen and Jialin Zheng

Pharmacological treatment for early and advanced stages of Parkinson’s disease: current and future strategies
Edited by Shengdi Chen and Jialin Zheng